We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$123M
AUM Growth
+$5.54M
Cap. Flow
-$158K
Cap. Flow %
-0.13%
Top 10 Hldgs %
35.93%
Holding
93
New
32
Increased
10
Reduced
17
Closed
31

Top Buys

Rank Stock Value
1
MYCC
ClubCorp Holdings, Inc.
MYCC
+$4.82M
2
ABBV icon
AbbVie
ABBV
+$3.75M
3
WBA
Walgreens Boots Alliance
WBA
+$3.28M
4
SHPG
Shire pic
SHPG
+$2.96M
5
TRIP icon
TripAdvisor
TRIP
+$2.82M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$3.61M
2
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
+$3.47M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$2.83M
5
SPLK
Splunk Inc
SPLK
+$2.7M

Sector Composition

Rank Sector Weight
1 Healthcare 37.6%
2 Communication Services 11.98%
3 Industrials 8.33%
4 Consumer Discretionary 7.51%
5 Materials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
51
Vanda Pharmaceuticals
VNDA
$306M
$712K 0.58%
44,000
+6,000
+16% +$79.9K
SLXP
52
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$678K 0.55%
+5,500
New +$608K
LYV icon
53
Live Nation Entertainment
LYV
$40.6B
$617K 0.5%
+25,000
New +$562K
AGIO icon
54
Agios Pharmaceuticals
AGIO
$1.83B
$550K 0.45%
12,000
-14,250
-54% -$581K
ICPT
55
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$521K 0.42%
2,200
-11,380
-84% -$3M
TUES
56
DELISTED
Tuesday Morning Corp
TUES
$463K 0.38%
+26,000
New +$406K
ITMN
57
CALL
DELISTED
INTERMUNE INC
ITMN
$375K 0.3%
8,500
– –
ISEE
58
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$360K 0.29%
+8,500
New +$312K
AVNR
59
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$310K 0.25%
+55,000
New +$253K
CORV
60
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$309K 0.25%
39,300
-700
-2% -$5.29K
ARCT icon
61
Arcturus Therapeutics
ARCT
$162M
$87K 0.07%
+714
New +$86.2K
ACAD icon
62
CALL
Acadia Pharmaceuticals
ACAD
$4.41B
$72K 0.06%
3,200
– –
ABUS icon
63
Arbutus Biopharma
ABUS
$847M
– –
-13,000
Closed -$279K
ARWR icon
64
Arrowhead Research
ARWR
$12.1B
– –
-16,000
Closed -$263K
BIIB icon
65
Biogen
BIIB
$30.4B
– –
-8,500
Closed -$2.6M
CTSH icon
66
Cognizant
CTSH
$24.9B
– –
-30,900
Closed -$1.56M
DDD icon
67
PUT
3D Systems Corp
DDD
$433M
– –
-11,000
Closed -$651K
HHH icon
68
Howard Hughes
HHH
$3.83B
– –
-6,504
Closed -$885K
IBB icon
69
PUT
iShares Biotechnology ETF
IBB
$9.36B
– –
-78,300
Closed -$6.17M
INCY icon
70
Incyte
INCY
$24.3B
– –
-67,500
Closed -$3.61M
LVS icon
71
Las Vegas Sands
LVS
$31.8B
– –
-24,500
Closed -$1.98M
NFLX icon
72
Netflix
NFLX
$299B
– –
-210,000
Closed -$1.06M
OMEX icon
73
Odyssey Marine Exploration
OMEX
$35.2M
– –
-14,623
Closed -$402K
PBYI icon
74
Puma Biotechnology
PBYI
$400M
– –
-11,350
Closed -$1.18M
PRTA icon
75
Prothena Corp
PRTA
$420M
– –
-57,500
Closed -$2.2M
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Atika Capital Management held 93 positions worth $123M, up 4.7% from $117M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Atika Capital Management's Q2 2014 filing shows 32 new, 10 increased, 17 reduced and 31 closed positions. Its largest new stake was ClubCorp Holdings, Inc.: 262,000 shares worth $4.86M. The largest sale was Incyte, an estimated $3.61M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Communication Services and Industrials.

  • Atika Capital Management's largest Q2 2014 buy was ClubCorp Holdings, Inc.: 262,000 shares worth $4.86M.
  • Atika Capital Management added most to INTERMUNE INC in Q2 2014, an estimated $2.17M increase.
  • Atika Capital Management's biggest Q2 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $3M.
  • Atika Capital Management fully exited Incyte in Q2 2014, selling an estimated $3.61M.
  • Atika Capital Management's ten largest holdings make up 36% of its $123M portfolio in Q2 2014.
  • Atika Capital Management opened 32 new positions and closed 31 in Q2 2014.
  • Atika Capital Management's portfolio value rose 4.7% quarter-over-quarter to $123M.

Based on Atika Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.